Dietary iron restriction improves aminotransferase levels in chronic hepatitis C patients

Hepato-Gastroenterology

Volumn 49, Issue 44, 2002, Pages 529-531

  Iwasa, Motoh ^a   Kaito, Masahiko ^a   Ikoma, Jiro ^a   Kobayashi, Yoshinao ^a   Tanaka, Yuji ^a   Higuchi, Kunihiro ^a   Takeuchi, Keisuke ^a   Iwata, Kazuko ^a   Watanabe, Shozo ^a   Adachi, Yukihiko ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic hepatitis C; Diet; Ferritin; Iron

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FERRITIN; INTERFERON; IRON; URSODEOXYCHOLIC ACID; AMINOTRANSFERASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY TITER; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; FEMALE; FERRITIN BLOOD LEVEL; HEPATITIS C; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON INTAKE; IRON OVERLOAD; LIVER FUNCTION TEST; MALE; PRIORITY JOURNAL; THROMBOCYTE COUNT; TREATMENT OUTCOME; BLOOD; ENZYMOLOGY; MIDDLE AGED;

ADULT; AGED; FEMALE; FERRITIN; HEPATITIS C, CHRONIC; HUMAN; IRON, DIETARY; LIVER FUNCTION TESTS; MALE; MIDDLE AGE; TRANSAMINASES; URSODEOXYCHOLIC ACID; FERRITINS; HUMANS; MIDDLE AGED;

EID: 0036016518     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Iron and chronic viral hepatitis
2. Measurements of iron status in patients with chronic hepatitis
3. Liver iron concentration in chronic viral hepatitis: A study of 98 patients
4. Iron overload in patients with chronic hepatitis C: A clinicopathologic study
5. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C
6. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron
7. Iron stores, response to α-interferon therapy, and effects of iron depletion in chronic hepatitis C
8. A pilot randomized, controlled trial of the effect of iron depletion on long-term response to α-interferon in patients with chronic hepatitis C
9. Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C
10. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis
11. Interferon and hepatitis C
12. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
13. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
14. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: A multicenter, prospective, randomized, controlled trial
15. Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants